SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-006354
Filing Date
2019-11-13
Accepted
2019-11-13 09:22:55
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 529367
2 CERTIFICATION ipix_ex311.htm EX-31.1 7946
3 CERTIFICATION ipix_ex312.htm EX-31.2 7935
4 CERTIFICATION ipix_ex321.htm EX-32.1 2792
5 CERTIFICATION ipix_ex322.htm EX-32.2 2854
  Complete submission text file 0001477932-19-006354.txt   4970286

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipix-20190930.xml EX-101.INS 824995
7 XBRL TAXONOMY EXTENSION SCHEMA ipix-20190930.xsd EX-101.SCH 85708
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20190930_lab.xml EX-101.LAB 455323
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20190930_cal.xml EX-101.CAL 46561
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20190930_pre.xml EX-101.PRE 447848
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20190930_def.xml EX-101.DEF 284952
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 191211928
SIC: 2834 Pharmaceutical Preparations